Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi-centre cohort study

被引:1
|
作者
De Luca, Joseph F. [1 ,2 ]
Awad, Andrew [1 ]
Vogrin, Sara [3 ]
Douglas, Abby P. [1 ]
Lutjen, Antje [4 ]
Gordon, Sally F. [5 ]
Crawford, Nigel W. [6 ,7 ]
Barnes, Sara [4 ]
Trubiano, Jason A. [1 ,2 ]
机构
[1] Ctr Antibiot Allergy & Res, Dept Infect Dis, Austin, Vic, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia
[4] Monash Hlth, Dept Allergy, Clayton, Vic, Australia
[5] Victorian Dept Hlth, COVID 19 Vaccinat Program, Vaccine Safety & Evaluat, Melbourne, Vic, Australia
[6] Victorian Vaccine Safety Serv, SAEFVIC, MCRI, Parkville, Vic, Australia
[7] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
关键词
allergy; challenge; COVID-19; SARS-CoV-2; vaccine;
D O I
10.1111/all.15467
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:293 / 296
页数:4
相关论文
共 50 条
  • [31] COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience
    Alobaidi, Sami
    Alsolami, Enad
    Sherif, Abdalla
    Almahdy, Mohammed
    Elmonier, Rady
    Alobaidi, Waad Y. Y.
    Akl, Ahmed
    VACCINES, 2023, 11 (01)
  • [32] Successful fractionated undiluted doses of COVID-19 vaccine in five cases of suspected allergic reactions to the first dose
    Rivolta, Federica
    Camilla, Cappelletti
    Sangalli, Andrea
    Gallo, Alessandra Chiei
    Pravettoni, Valerio
    CLINICAL CASE REPORTS, 2022, 10 (10):
  • [33] Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
    Tobaiqy, Mansour
    Elkout, Hajer
    MacLure, Katie
    VACCINES, 2021, 9 (04)
  • [34] Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
    Pang, Kunpeng
    Pan, Lijie
    Guo, Hui
    Wu, Xinyi
    FRONTIERS IN MEDICINE, 2022, 8
  • [35] Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study
    Abdulah, Deldar Morad
    Mirza, Abbas Muhammed Sadiq
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (01)
  • [36] Two versus three doses of COVID-19 vaccine and post-vaccination COVID-19 infection in hemodialysis patients
    Ahmed, Laila A.
    Mansour, Hayam H.
    Elshennawy, Salwa I.
    Ramadan, Marwa A. A.
    Kamal, Mohamed A. M.
    Mohamed, Soso S.
    Ali, Omaima Mohamed
    Ibrhim, Amal H.
    INFECTION PREVENTION IN PRACTICE, 2024, 6 (01)
  • [37] A Multi-Centre COVID-19 Study Examining Symptoms and Medication Use in the Final Week of Life
    Wong, Aaron K.
    Philip, Jennifer
    Wawryk, Olivia
    Sabe, Michael G.
    Yoong, Jaclyn
    Everitt, Rachel
    Mendis, Ruwani
    Chua, Joyce
    Pisasale, Maria
    Le, Brian
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 64 (03) : E139 - E147
  • [38] Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination
    Jiang, Manling
    Yu, Haiqiong
    Luo, Li
    Zhang, Lei
    Xiong, Anying
    Wang, Junyi
    Wang, Qianhui
    Liu, Yao
    Liu, Shengbin
    Xiong, Ying
    Yang, Pingchang
    Chang, Christopher
    Zhang, Jianquan
    He, Xiang
    Li, Guoping
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [39] Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)
    Baos, Sarah
    Todd, Rachel
    Thirard, Russell
    Harris, Rosie
    Kirwan, Jana
    Joyce, Katherine
    Hutton, David
    Finn, Adam
    Clout, Madeleine
    Cappel-Porter, Heike
    Rogers, Chris A.
    Lazarus, Rajeka
    Culliford, Lucy
    TRIALS, 2024, 25 (01)
  • [40] BAYESIAN LEARNING OF COVID-19 VACCINE SAFETY WHILE INCORPORATING ADVERSE EVENTS ONTOLOGY
    Zhao, Bangyao
    Zhong, Yuan
    Kang, Jian
    Zhao, Lili
    ANNALS OF APPLIED STATISTICS, 2023, 17 (04) : 2887 - 2902